2024 / Therapies, Duchenne, Exon skipping, Mutation-specific therapy, Treatment access

Exon skipping therapies in DMD: a case series of children who initiated before 3 years of age

Poster

These 5 cases illustrate that initiation of exon skipping therapies before age 3 is feasible and provide further evidence of safety. Based upon extrapolation from other studies, treatment in this age group is likely to provide long-term benefits.

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo